                         SEQUENCE LISTING

<110>  Biokine Therapeutics Ltd.
       BioLineRx Ltd.
       PELED, Amnon
       PEREG, Yaron
       ABRAHAM, Michal
       KLEIN SILBERMAN, Shiri
 
<120>  CXCR4 BINDING AGENTS FOR TREATMENT OF DISEASES

<130>  66488

<150>  US 62/200,177
<151>  2015-08-03

<160>  14    

<170>  PatentIn version 3.5

<210>  1
<211>  9
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  oligonucleotide sequences that can be used to form a loop

<400>  1
uucaagaga                                                                9


<210>  2
<211>  9
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  oligonucleotide sequences that can be used to form a loop

<400>  2
uuuguguag                                                                9


<210>  3
<211>  22
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  miRNA

<400>  3
uagcagcaca uaaugguuug ug                                                22


<210>  4
<211>  22
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  miRNA

<400>  4
uagcagcacg uaaauauugg cg                                                22


<210>  5
<211>  18
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  18-mer antisense  oligodeoxynucleotide


<220>
<221>  misc_feature
<222>  (1)..(18)
<223>  phosphorothioate oligodeoxynucleotides backbone

<400>  5
tctcccagcg tgcgccat                                                     18


<210>  6
<211>  16
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  16-mer antisense oligonucleotide


<220>
<221>  misc_feature
<222>  (1)..(16)
<223>  phosphorothioate oligodeoxynucleotide backbone

<220>
<221>  misc_feature
<222>  (1)..(2)
<223>  locked nucleic acid (LNA) nucleotides

<220>
<221>  misc_feature
<222>  (14)..(15)
<223>  locked nucleic acid (LNA) nucleotides

<400>  6
ctcccaacgt gcgcca                                                       16


<210>  7
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  siRNA

<400>  7
gcatgcggcc tctgtttgat t                                                 21


<210>  8
<211>  19
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  siRNA

<400>  8
tccaaggcat gcttcggaa                                                    19


<210>  9
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  siRNA

<400>  9
ccagagugau caagugugat t                                                 21


<210>  10
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  oligonucleotide probe

<400>  10
uagcagcaca uaaugguuug ug                                                22


<210>  11
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  oligonucleotide probe

<400>  11
uagcagcacg uaaauauugg cg                                                22


<210>  12
<211>  89
<212>  PRT
<213>  Homo sapiens


<220>
<221>  misc_feature
<223>  Human SDF-1 alpha

<400>  12

Met Asn Ala Lys Val Val Val Val Leu Val Leu Val Leu Thr Ala Leu 
1               5                   10                  15      


Cys Leu Ser Asp Gly Lys Pro Val Ser Leu Ser Tyr Arg Cys Pro Cys 
            20                  25                  30          


Arg Phe Phe Glu Ser His Val Ala Arg Ala Asn Val Lys His Leu Lys 
        35                  40                  45              


Ile Leu Asn Thr Pro Asn Cys Ala Leu Gln Ile Val Ala Arg Leu Lys 
    50                  55                  60                  


Asn Asn Asn Arg Gln Val Cys Ile Asp Pro Lys Leu Lys Trp Ile Gln 
65                  70                  75                  80  


Glu Tyr Leu Glu Lys Ala Leu Asn Lys 
                85                  


<210>  13
<211>  89
<212>  PRT
<213>  Mus musculus


<220>
<221>  misc_feature
<223>  Murine SDF-1 alpha

<400>  13

Met Asp Ala Lys Val Val Ala Val Leu Ala Leu Val Leu Ala Ala Leu 
1               5                   10                  15      


Cys Ile Ser Asp Gly Lys Pro Val Ser Leu Ser Tyr Arg Cys Pro Cys 
            20                  25                  30          


Arg Phe Phe Glu Ser His Ile Ala Arg Ala Asn Val Lys His Leu Lys 
        35                  40                  45              


Ile Leu Asn Thr Pro Asn Cys Ala Leu Gln Ile Val Ala Arg Leu Lys 
    50                  55                  60                  


Asn Asn Asn Arg Gln Val Cys Ile Asp Pro Lys Leu Lys Trp Ile Gln 
65                  70                  75                  80  


Glu Tyr Leu Glu Lys Ala Leu Asn Lys 
                85                  


<210>  14
<211>  14
<212>  PRT
<213>  Artificial

<220>
<223>  synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  4-fluorobenzoyl-arginine

<220>
<221>  MOD_RES
<222>  (3)..(3)
<223>  3-((2-naphthyl) alanine

<220>
<221>  MOD_RES
<222>  (6)..(6)
<223>  citrulline

<220>
<221>  MOD_RES
<222>  (8)..(8)
<223>  D-lysine

<220>
<221>  MOD_RES
<222>  (12)..(12)
<223>  citrulline

<220>
<221>  MOD_RES
<222>  (14)..(14)
<223>  C' AMIDATED

<400>  14

Xaa Arg Xaa Cys Tyr Xaa Lys Xaa Pro Tyr Arg Xaa Cys Arg 
1               5                   10                  


